ESMO Preceptorship on Prostate Cancer Singapore 2016

Oncology Meeting Resources

15 Dec - 16 Dec, Singapore, Singapore

ESMO Preceptorship on Prostate Cancer

The ESMO Preceptorship on Prostate Cancer Singapore 2016 was designed for learning about fundamentals of epidemiology, natural history and diagnosis as contributing factors to heterogeneity in prostate cancer, understanding essentials in the assessment and multidisciplinary treatment of prostate cancer and learning about advances in treatment and novel targets in prostate cancer.

Presentations of the ESMO Preceptorship on Prostate Cancer Singapore 2016 are available to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful links

Presenter Presentation title Session title
D. Y. C. Heng, CA PSA Screening and Diagnosis Session 1 Screening, Diagnosis and Staging
T. P. Hoon, SG Diagnosis and Impact of Pathology on Prognosis Session 1 Screening, Diagnosis and Staging
J. W. Kwek, SG Imaging Tests and Staging Classification Session 1 Screening, Diagnosis and Staging
J. Tuan, SG Role of Radiotherapy Session 2 Localized Prostate Cancer
L. L. Shiong, SG Role of Surgery Session 2 Localized Prostate Cancer
A. Giselvania, ID Prostate Cancer Case Session 2 Localized Prostate Cancer
S. R. Keesara, IN A Case of Localized High Risk Carcinoma Prostate Session 2 Localized Prostate Cancer
D. Y. C. Heng, CA Presentation with Lymphadenopathy and Value and Role Of PSA as a Tumour Marker of Response/Relapse Session 3 Advanced Prostate Cancer
L. L. Shiong, SG Managing Urinary Obstruction Session 3 Advanced Prostate Cancer
J. Tuan, SG Argument For Session 3 Advanced Prostate Cancer
L. L. Shiong, SG Argument Against Session 3 Advanced Prostate Cancer
J. Goswami, IN High-Risk Localised Prostate Cancer: Response Evaluation & Follow-up in a Non-Secretor Session 3 Advanced Prostate Cancer
D. M . Joseph, IN Radical Radiotherapy in Carcinoma Prostate with Pelvic Lymphadenopathy Session 3 Advanced Prostate Cancer
R. Kanesvaran, SG First and Second-Line Chemotherapy in Castration Resistance. When to Use it Session 4 Initial Systemic Therapy
S. Ali, MY High Grade Neuroendocrine Tumor of Prostate with Muscle and Nodal Met without Osseous Metastasis Session 4 Initial Systemic Therapy